AR070473A2 - Compuestos inhibidores de la renina, un procedimiento de preparacion del compuesto, una composicion farmaceutica, uso del compuesto para preparar un medicamento y compuesto intermediario - Google Patents
Compuestos inhibidores de la renina, un procedimiento de preparacion del compuesto, una composicion farmaceutica, uso del compuesto para preparar un medicamento y compuesto intermediarioInfo
- Publication number
- AR070473A2 AR070473A2 ARP090100634A ARP090100634A AR070473A2 AR 070473 A2 AR070473 A2 AR 070473A2 AR P090100634 A ARP090100634 A AR P090100634A AR P090100634 A ARP090100634 A AR P090100634A AR 070473 A2 AR070473 A2 AR 070473A2
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- compounds
- rhinine
- prepare
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Abstract
Los compuestos son utiles para el tratamiento de enfermedades que están asociadas con la restenosis, glaucoma, infarto cardíaco, presion sanguínea elevada y lesiones en el organo final. Por ej., insuficiencia cardíaca e insuficiencia renal. Reivindicacion 1: Compuestos de formula (1) en donde R1 es naftilo opcionalmente sustituido por uno a tres grupos alcoxilo C1-5; R2 es fenilo o bencilo, opcionalmente sustituido por sustituyentes seleccionados independientemente entre uno a tres grupos halogeno, ciano, alcoxilo C1-3 y nitro; R3 es H-[CH(OR4)]2-CH2-O-CH2- o R3a-(CH2)k-[CH(OR4)]l-CH2-O-; R3a es hidroxilo o alcoxilo C1-3; R4 es hidrogeno o C1-3-alquilo; k es 1 o 2; l es 1 o 2; y sales farmacéuticamente aceptables de los mismos. Reivindicacion 31: Los compuestos de formula (2) en donde P1 representa un grupo protector de NH usual tal como tert-butoxicarbonilo, benciloxicarbonilo, aliloxicarbonilo, viniloxicarbonilo, alquilsililalquiloxicarbonilo tal como 2-(trimetilsilil)etoxicarbonilo, y tricloroetoxicarbonilo; y R1, R2 y R3 son como se ha definido en la reivindicacion 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99108199 | 1999-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR070473A2 true AR070473A2 (es) | 2010-04-07 |
Family
ID=8238050
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101954A AR018719A1 (es) | 1999-04-27 | 2000-04-26 | Inhibidores de renina. |
ARP090100634A AR070473A2 (es) | 1999-04-27 | 2009-02-25 | Compuestos inhibidores de la renina, un procedimiento de preparacion del compuesto, una composicion farmaceutica, uso del compuesto para preparar un medicamento y compuesto intermediario |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101954A AR018719A1 (es) | 1999-04-27 | 2000-04-26 | Inhibidores de renina. |
Country Status (35)
Country | Link |
---|---|
US (2) | US6376672B1 (es) |
EP (1) | EP1175400B1 (es) |
JP (1) | JP3808706B2 (es) |
KR (1) | KR100443684B1 (es) |
CN (1) | CN1147471C (es) |
AR (2) | AR018719A1 (es) |
AT (1) | ATE512949T1 (es) |
AU (1) | AU763718B2 (es) |
BR (1) | BR0010080B1 (es) |
CA (1) | CA2370888C (es) |
CO (1) | CO5170513A1 (es) |
CZ (1) | CZ302012B6 (es) |
DK (1) | DK1175400T3 (es) |
EG (1) | EG23979A (es) |
ES (1) | ES2366668T3 (es) |
GC (1) | GC0000251A (es) |
HK (1) | HK1045999B (es) |
HR (1) | HRP20010762A2 (es) |
HU (1) | HU227764B1 (es) |
IL (2) | IL146002A0 (es) |
JO (1) | JO2256B1 (es) |
MA (1) | MA26787A1 (es) |
MX (1) | MXPA01010934A (es) |
MY (1) | MY127894A (es) |
NO (1) | NO320803B1 (es) |
NZ (1) | NZ514981A (es) |
PE (1) | PE20010069A1 (es) |
PL (1) | PL199895B1 (es) |
PT (1) | PT1175400E (es) |
RS (1) | RS51156B (es) |
RU (1) | RU2213731C2 (es) |
TR (1) | TR200103095T2 (es) |
TW (1) | TWI224593B (es) |
WO (1) | WO2000064873A1 (es) |
ZA (1) | ZA200108735B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6376672B1 (en) * | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
US6835686B2 (en) * | 2001-07-05 | 2004-12-28 | Millennium Specialty Chemicals | Catalyst system and process for rearrangement of epoxides to allylic alcohols |
BR0312000A (pt) * | 2002-06-27 | 2005-03-22 | Actelion Pharmaceuticals Ltd | Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos |
US20040214832A1 (en) * | 2003-04-10 | 2004-10-28 | Cuiman Cai | Piperazine derivative renin inhibitors |
DE602004010385D1 (de) * | 2003-04-29 | 2008-01-10 | Actelion Pharmaceuticals Ltd | 3,4-disubstituierte 1,2,3,4-tetrahydropyridinderivate |
TW200900399A (en) * | 2003-10-01 | 2009-01-01 | Speedel Experimenta Ag | Organic compounds |
AR045950A1 (es) * | 2003-10-09 | 2005-11-16 | Speedel Experimenta Ag | Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. |
WO2005037317A2 (en) * | 2003-10-17 | 2005-04-28 | Cornell Research Foundation, Inc. | Mast cell-derived renin |
CA2546264A1 (en) * | 2003-11-26 | 2005-06-09 | Novartis Ag | 4-phenylpiperidine derivatives as renin inhibitors |
AR053406A1 (es) * | 2004-07-09 | 2007-05-09 | Speedel Experimenta Ag | Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas |
EP1799199B1 (en) | 2004-10-08 | 2012-03-28 | Novartis AG | Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
GB0500784D0 (en) * | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
EP1707202A1 (de) * | 2005-03-31 | 2006-10-04 | Speedel Experimenta AG | Organische Verbindungen |
AR055756A1 (es) * | 2005-03-31 | 2007-09-05 | Speedel Experimenta Ag | Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos |
TW200722424A (en) * | 2005-03-31 | 2007-06-16 | Speedel Experimenta Ag | Substituted piperidines |
EP1897879A3 (en) * | 2005-03-31 | 2008-06-11 | Speedel Experimenta AG | 2,4,5-substituted piperidines as renin inhibitors |
BRPI0609534A2 (pt) * | 2005-03-31 | 2010-04-13 | Speedel Experimenta Ag | piperidinas 3,4,5-substituìdas |
ES2352564T3 (es) * | 2005-03-31 | 2011-02-21 | Novartis Ag | Piperidinas sustituidas. |
JP4297972B2 (ja) | 2005-05-27 | 2009-07-15 | アクテリオン ファーマシューティカルズ リミテッド | 新規なピペリジンカルボン酸アミド誘導体 |
GB0514203D0 (en) * | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
BRPI0617621A2 (pt) * | 2005-10-21 | 2011-08-02 | Novartis Ag | combinação de compostos orgánicos |
CN101356156B (zh) * | 2005-11-14 | 2012-12-05 | 生命医药公司 | 天冬氨酸蛋白酶抑制剂 |
PT2420491E (pt) * | 2005-12-30 | 2013-10-14 | Novartis Ag | Compostos de piperidina 3,5-substituída como inibidores de renina |
TW200804359A (en) | 2006-01-19 | 2008-01-16 | Speedel Experimenta Ag | Substituted 4-phenylpiperidines |
EP1816122A3 (en) * | 2006-01-19 | 2007-09-19 | Speedel Experimenta AG | 3,4,5-substituted piperidines as therapeutic compounds |
TW200821303A (en) * | 2006-08-08 | 2008-05-16 | Speedel Experimenta Ag | Organic compounds |
WO2008021552A2 (en) * | 2006-08-18 | 2008-02-21 | Duke University | Biased ligands and methods of identifying same |
EP1908761A1 (en) * | 2006-10-04 | 2008-04-09 | Speedel Experimenta AG | Organic compounds |
EP1911758A1 (en) * | 2006-10-04 | 2008-04-16 | Speedel Experimenta AG | Phenyl piperidine derivatives for use as renin inhibitors |
ES2541107T3 (es) | 2007-06-25 | 2015-07-16 | Novartis Ag | Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina |
JP2011503022A (ja) * | 2007-11-02 | 2011-01-27 | ノバルティス アーゲー | レニン阻害剤としての4,4−二置換ピペリジン |
US10517839B2 (en) | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
WO2011045244A1 (en) | 2009-10-14 | 2011-04-21 | Rainer Oberbauer | Acute kidney injury risk testing |
WO2013045505A1 (en) | 2011-09-28 | 2013-04-04 | Novartis Ag | Biomarkers for raas combination therapy |
EP2810644A1 (en) | 2013-06-06 | 2014-12-10 | Ferrer Internacional, S.A. | Oral formulation for the treatment of cardiovascular diseases |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK231088D0 (da) | 1988-04-28 | 1988-04-28 | Ferrosan As | Piperidinforbindelser, deres fremstilling og anvendelse |
DE3640475A1 (de) | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
WO1993000042A1 (en) | 1991-06-24 | 1993-01-07 | B.V. Optische Industrie 'de Oude Delft' | Device for measuring the respiration of a person |
WO1997003911A1 (de) | 1995-07-24 | 1997-02-06 | Railfix N.V. | Elektro-permanentmagnetsystem zum manövrieren von einer magnetischen insbesondere ferromagnetischen last |
CN1256326C (zh) | 1995-09-07 | 2006-05-17 | 弗·哈夫曼-拉罗切有限公司 | 治疗心脏和肾功能不全的新型4-(氧烷氧基苯基)-3-氧哌啶化合物 |
AU9740998A (en) * | 1997-09-08 | 1999-03-29 | F. Hoffmann-La Roche Ag | Piperidine derivatives against malaria |
US6376672B1 (en) * | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
-
2000
- 2000-04-04 US US09/542,303 patent/US6376672B1/en not_active Expired - Fee Related
- 2000-04-19 HU HU0203669A patent/HU227764B1/hu not_active IP Right Cessation
- 2000-04-19 TR TR2001/03095T patent/TR200103095T2/xx unknown
- 2000-04-19 PL PL353442A patent/PL199895B1/pl not_active IP Right Cessation
- 2000-04-19 BR BRPI0010080-3A patent/BR0010080B1/pt not_active IP Right Cessation
- 2000-04-19 CA CA002370888A patent/CA2370888C/en not_active Expired - Fee Related
- 2000-04-19 PT PT00922651T patent/PT1175400E/pt unknown
- 2000-04-19 IL IL14600200A patent/IL146002A0/xx active IP Right Grant
- 2000-04-19 RS YUP-771/01A patent/RS51156B/sr unknown
- 2000-04-19 ES ES00922651T patent/ES2366668T3/es not_active Expired - Lifetime
- 2000-04-19 EP EP00922651A patent/EP1175400B1/en not_active Expired - Lifetime
- 2000-04-19 TW TW089107377A patent/TWI224593B/zh not_active IP Right Cessation
- 2000-04-19 AT AT00922651T patent/ATE512949T1/de active
- 2000-04-19 RU RU2001130163/04A patent/RU2213731C2/ru not_active IP Right Cessation
- 2000-04-19 WO PCT/EP2000/003555 patent/WO2000064873A1/en active IP Right Grant
- 2000-04-19 NZ NZ514981A patent/NZ514981A/xx not_active IP Right Cessation
- 2000-04-19 CN CNB008068003A patent/CN1147471C/zh not_active Expired - Fee Related
- 2000-04-19 KR KR10-2001-7013696A patent/KR100443684B1/ko not_active IP Right Cessation
- 2000-04-19 AU AU42968/00A patent/AU763718B2/en not_active Ceased
- 2000-04-19 JP JP2000613826A patent/JP3808706B2/ja not_active Expired - Fee Related
- 2000-04-19 CZ CZ20013854A patent/CZ302012B6/cs not_active IP Right Cessation
- 2000-04-19 MX MXPA01010934A patent/MXPA01010934A/es active IP Right Grant
- 2000-04-19 DK DK00922651.5T patent/DK1175400T3/da active
- 2000-04-23 JO JO200063A patent/JO2256B1/en active
- 2000-04-24 EG EG20000523A patent/EG23979A/xx active
- 2000-04-25 PE PE2000000386A patent/PE20010069A1/es not_active Application Discontinuation
- 2000-04-25 GC GCP2000632 patent/GC0000251A/en active
- 2000-04-25 MY MYPI20001771A patent/MY127894A/en unknown
- 2000-04-26 AR ARP000101954A patent/AR018719A1/es active IP Right Grant
- 2000-04-26 CO CO00029975A patent/CO5170513A1/es not_active Application Discontinuation
-
2001
- 2001-10-17 IL IL146002A patent/IL146002A/en not_active IP Right Cessation
- 2001-10-19 HR HR20010762A patent/HRP20010762A2/xx not_active Application Discontinuation
- 2001-10-23 ZA ZA200108735A patent/ZA200108735B/xx unknown
- 2001-10-25 NO NO20015206A patent/NO320803B1/no not_active IP Right Cessation
- 2001-10-26 MA MA26386A patent/MA26787A1/fr unknown
- 2001-12-18 US US10/023,679 patent/US6673931B2/en not_active Expired - Fee Related
-
2002
- 2002-10-22 HK HK02107639.0A patent/HK1045999B/zh not_active IP Right Cessation
-
2009
- 2009-02-25 AR ARP090100634A patent/AR070473A2/es active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR070473A2 (es) | Compuestos inhibidores de la renina, un procedimiento de preparacion del compuesto, una composicion farmaceutica, uso del compuesto para preparar un medicamento y compuesto intermediario | |
AR018717A1 (es) | COMPUESTOS DERIVADOS DE PIPERIDINA, SU USO, UN PROCESO PARA SU PREPARACIoN, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, Y COMPUESTOS INTERMEDIARIOS. | |
PA8432901A1 (es) | Compuestos de piridilpirrol | |
NO981911L (no) | Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom | |
AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
BR0313942A (pt) | Derivados de benzimidazol úteis como agentes antiproliferativos | |
BRPI0516453A (pt) | derivados de benzoimidazol úteis como agentes antiproliferativos | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
AR005053A1 (es) | Compuestos de difenilhexano, un procedimiento para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos, y procedmientos para la manufactura de medicamentos para inhibir la infeccion de hiv | |
BR0317435A (pt) | Derivados de pirimidina para o tratamento do crescimento celular anormal | |
BR9807876A (pt) | Compostos heterocìclicos e seu uso para inibição de peptìdeo beta-amilóide | |
ES2196377T3 (es) | Derivados de naftiridina. | |
YU20999A (sh) | Heterociklični derivati koji inhibiraju faktor xa | |
AR035482A1 (es) | Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos | |
AR012964A1 (es) | Compuetos derivados de bencimidazol, composiciones farmaceuticas que los contienen y su uso en la manufactura de medicamentos para tratar infeccionesvirales | |
HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AR032778A1 (es) | Benzimidazoles sustituidos, y su utilizacion para la preparacion de medicamento | |
BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
FI963508A0 (fi) | 3,5-disubstituoituja ja 3,5,6-trisubstituoituja 2-isoksatsoliineja ja isoksatsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
AR043259A1 (es) | Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
DK0527081T3 (da) | Hidtil ukendte substituerede 3-piperazinylalkyl-2,3-dihydro-1,3-4H-benzoxazin-4-oner, deres fremstilling og terapeutiske anvendelse | |
AR013241A1 (es) | Derivados del acido aminoetilfenoxiacetico, composicion farmaceutica que incluye a dicho derivado, medicamento para reducir el dolor y promover la eliminacion de calculos en urolitiasis, utilizacion de dicho derivado para la fabricacion de dicha composicion farmaceutica y procedimiento para la fabri | |
AR016386A1 (es) | D- o l-lixofuranosil benzimidazoles composicion que los contiene, procedimiento para su preparacion y su uso para la manufactura de un medicamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |